Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas - PubMed (original) (raw)
Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas
G L Shen-Ong et al. Cell. 1982 Dec.
Abstract
We have found that the myc oncogene has been modified by abortive recombination with the alpha heavy-chain immunoglobulin constant-region (C alpha) gene in five different mouse plasmacytoma lines. Recombination occurred approximately 0.8-2.0 kb to the 5' side of two distinct coding regions, defined by sequence homology between the chicken cellular and plasmacytoma myc genes. The myc and C alpha genes were always in opposite transcriptional orientation, with the recombination site within the C alpha switch region sequences. DNA recombination was found to correlate with the production of a novel 2.1 kb species of myc RNA that was 0.4 kb shorter than the normal cellular transcript. No elevated levels of myc RNA were evident, suggesting that DNA rearrangements have altered the myc oncogene product. This oncogene activation corresponds to the chromosomal translocations found in nearly all plasmacytomas.
Similar articles
- DNA sequences near the site of reciprocal recombination between a c-myc oncogene and an immunoglobulin switch region.
Dunnick W, Shell BE, Dery C. Dunnick W, et al. Proc Natl Acad Sci U S A. 1983 Dec;80(23):7269-73. doi: 10.1073/pnas.80.23.7269. Proc Natl Acad Sci U S A. 1983. PMID: 6316351 Free PMC article. - Recombination events near the immunoglobulin Cmu gene join variable and constant region genes, switch heavy-chain expression, or inactivate the locus.
Cory S, Webb E, Gough J, Adams JM. Cory S, et al. Biochemistry. 1981 Apr 28;20(9):2662-71. doi: 10.1021/bi00512a047. Biochemistry. 1981. PMID: 6263315 - Molecular cloning of translocations involving chromosome 15 and the immunoglobulin C alpha gene from chromosome 12 in two murine plasmacytomas.
Calame K, Kim S, Lalley P, Hill R, Davis M, Hood L. Calame K, et al. Proc Natl Acad Sci U S A. 1982 Nov;79(22):6994-8. doi: 10.1073/pnas.79.22.6994. Proc Natl Acad Sci U S A. 1982. PMID: 6960358 Free PMC article. - Rearrangements of immunoglobulin genes during differentiation and evolution.
Honjo T, Nakai S, Nishida Y, Kataoka T, Yamawaki-Kataoka Y, Takahashi N, Obata M, Shimizu A, Yaoita Y, Nikaido T, Ishida N. Honjo T, et al. Immunol Rev. 1981;59:33-67. doi: 10.1111/j.1600-065x.1981.tb00455.x. Immunol Rev. 1981. PMID: 6796498 Review. - Organization and expression of murine immunoglobulin genes.
Adams JM, Kemp DJ, Bernard O, Gough N, Webb E, Tyler B, Gerondakis S, Cory S. Adams JM, et al. Immunol Rev. 1981;59:5-32. doi: 10.1111/j.1600-065x.1981.tb00454.x. Immunol Rev. 1981. PMID: 6273295 Review. No abstract available.
Cited by
- Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity.
Lind J, Aksoy O, Prchal-Murphy M, Fan F, Fulciniti M, Stoiber D, Bakiri L, Wagner EF, Zwickl-Traxler E, Sattler M, Kollmann K, Vallet S, Podar K. Lind J, et al. Blood Cancer J. 2024 Aug 19;14(1):138. doi: 10.1038/s41408-024-01117-4. Blood Cancer J. 2024. PMID: 39160158 Free PMC article. - Immunocompetent Mouse Models of Multiple Myeloma: Therapeutic Implications.
Du MT, Bergsagel PL, Chesi M. Du MT, et al. Hematol Oncol Clin North Am. 2024 Apr;38(2):533-546. doi: 10.1016/j.hoc.2023.12.014. Epub 2024 Jan 16. Hematol Oncol Clin North Am. 2024. PMID: 38233233 Review. - Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.
Pisano M, Cheng Y, Sun F, Dhakal B, D'Souza A, Chhabra S, Knight JM, Rao S, Zhan F, Hari P, Janz S. Pisano M, et al. Front Immunol. 2021 Jun 2;12:667054. doi: 10.3389/fimmu.2021.667054. eCollection 2021. Front Immunol. 2021. PMID: 34149703 Free PMC article. Review. - The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance.
Kumari A, Folk WP, Sakamuro D. Kumari A, et al. Genes (Basel). 2017 Jun 7;8(6):158. doi: 10.3390/genes8060158. Genes (Basel). 2017. PMID: 28590415 Free PMC article. Review. - Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.
Rosean TR, Tompkins VS, Tricot G, Holman CJ, Olivier AK, Zhan F, Janz S. Rosean TR, et al. Immunol Res. 2014 Aug;59(1-3):188-202. doi: 10.1007/s12026-014-8528-x. Immunol Res. 2014. PMID: 24845460 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases